Grifols partners with Canadian Blood Services to accelerate immunoglobulin self-sufficiency in Canada
Grifols se une a Canadian Blood Services para para acelerar la autosuficiencia de inmunoglobulinas en Canadá
Intel ID : 350607
|
||||
| Intel ID | 350607 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Grifols
(31 Dec 2021) |
Revenue: EUR 5.157,31m EBITDA: EUR 973,34m Net Debt: EUR 78.219,61m |
||
| Date |
 |
||
| Country | |
||
| Geography |  |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 50.02.02 Charity, Grantmaking & Giving Services NGOs (Primary) 50 Public Services & NGOs / 50.02 Non-Governmental Institutions, Organizations & Associations |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
50.02.02 Charity, Grantmaking & Giving Services NGOs 50 Public Services & NGOs / 50.02 Non-Governmental Institutions, Organizations & Associations |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legal Advisory
| Parties | Advisor | Type | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|---|
|
-
- - - |
- | - |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.